Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kian Ang

Showing results (91-100 of 206) with videos related to

Pageof 21
Sort By:
International Journal of Radiation Oncology, Biology, Physics|September 25, 2007
Targeted therapy against VEGFR and EGFR with ZD6474 enhances the therapeutic efficacy of irradiation in an orthotopic model of human non-small-cell lung cancerKeiko Shibuya, Ritsuko Komaki, Tomoaki Shintani, et al.
Cancer|June 10, 2011
Outcomes of malignant tumors of the lacrimal apparatus: the University of Texas MD Anderson Cancer Center experienceHeath D Skinner, Adam S Garden, David I Rosenthal, et al.
Molecular Cell|September 29, 2009
Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiationXin Huang, Lianghao Ding, Kevin L Bennewith, et al.
International Journal of Radiation Oncology, Biology, Physics|October 8, 2003
P105 as a prognostic indicator in patients irradiated for locally advanced head-and-neck cancer: a clinical/laboratory correlative analysis of RTOG-9003E Hammond, Brian A Berkey, Karen K Fu, et al.
International Journal of Radiation Oncology, Biology, Physics|May 1, 2012
A phase II study of submandibular gland transfer prior to radiation for prevention of radiation-induced xerostomia in head-and-neck cancer (RTOG 0244)Naresh Jha, Jonathan Harris, Hadi Seikaly, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 9, 2012
Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancerMaura L Gillison, Qiang Zhang, Richard Jordan, et al.
Cancer|April 8, 2011
Longitudinal Oncology Registry of Head and Neck Carcinoma (LORHAN): analysis of chemoradiation treatment approaches in the United StatesStuart J Wong, Paul M Harari, Adam S Garden, et al.
Practical Radiation Oncology|March 14, 2014
Auto-segmentation of low-risk clinical target volume for head and neck radiation therapyJinzhong Yang, Beth M Beadle, Adam S Garden, et al.
Cancer|March 17, 2004
Is concurrent chemoradiation the treatment of choice for all patients with Stage III or IV head and neck carcinoma?Adam S Garden, Joshua A Asper, William H Morrison, et al.
Cancer|December 17, 2013
Risk factors for clinician-reported symptom clusters in patients with advanced head and neck cancer in a phase 3 randomized clinical trial: RTOG 0129Canhua Xiao, Alexandra Hanlon, Qiang Zhang, et al.
Pageof 21

Showing results (91-100 of 206) with videos related to

Sort By:
Pageof 21
International Journal of Radiation Oncology, Biology, Physics|September 25, 2007
Targeted therapy against VEGFR and EGFR with ZD6474 enhances the therapeutic efficacy of irradiation in an orthotopic model of human non-small-cell lung cancerKeiko Shibuya, Ritsuko Komaki, Tomoaki Shintani, et al.
Cancer|June 10, 2011
Outcomes of malignant tumors of the lacrimal apparatus: the University of Texas MD Anderson Cancer Center experienceHeath D Skinner, Adam S Garden, David I Rosenthal, et al.
Molecular Cell|September 29, 2009
Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiationXin Huang, Lianghao Ding, Kevin L Bennewith, et al.
International Journal of Radiation Oncology, Biology, Physics|October 8, 2003
P105 as a prognostic indicator in patients irradiated for locally advanced head-and-neck cancer: a clinical/laboratory correlative analysis of RTOG-9003E Hammond, Brian A Berkey, Karen K Fu, et al.
International Journal of Radiation Oncology, Biology, Physics|May 1, 2012
A phase II study of submandibular gland transfer prior to radiation for prevention of radiation-induced xerostomia in head-and-neck cancer (RTOG 0244)Naresh Jha, Jonathan Harris, Hadi Seikaly, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 9, 2012
Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancerMaura L Gillison, Qiang Zhang, Richard Jordan, et al.
Cancer|April 8, 2011
Longitudinal Oncology Registry of Head and Neck Carcinoma (LORHAN): analysis of chemoradiation treatment approaches in the United StatesStuart J Wong, Paul M Harari, Adam S Garden, et al.
Practical Radiation Oncology|March 14, 2014
Auto-segmentation of low-risk clinical target volume for head and neck radiation therapyJinzhong Yang, Beth M Beadle, Adam S Garden, et al.
Cancer|March 17, 2004
Is concurrent chemoradiation the treatment of choice for all patients with Stage III or IV head and neck carcinoma?Adam S Garden, Joshua A Asper, William H Morrison, et al.
Cancer|December 17, 2013
Risk factors for clinician-reported symptom clusters in patients with advanced head and neck cancer in a phase 3 randomized clinical trial: RTOG 0129Canhua Xiao, Alexandra Hanlon, Qiang Zhang, et al.
Pageof 21